Jci_page_head_homepage_01 Jci_page_head_homepage_02
Daniela Cota, Giovanni Marsicano, Matthias Tschöp, Yvonne Grübler, Cornelia Flachskamm, Mirjam Schubert, Dorothee Auer, Alexander Yassouridis, Christa Thöne-Reineke, Sylvia Ortmann, Federica Tomassoni, Cristina Cervino, Enzo Nisoli, Astrid C.E. Linthorst, Renato Pasquali, Beat Lutz, Günter K. Stalla, Uberto Pagotto
Published in Volume 112, Issue 3
J Clin Invest. 2003; 112(3):423 doi:10.1172/JCI17725
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 7 7 6 21 33 26 18 4 1 123

Citations to this article in CrossRef (123)

Title and authors Publication Year
The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice
Zhen Pang, Nancy N. Wu, Weiguang Zhao, David C. Chain, Erica Schaffer, Xin Zhang, Preeti Yamdagni, Vaseem A. Palejwala, Chunpeng Fan, Sarah G. Favara, Holly M. Dressler, Kyriakos D. Economides, Daniel Weinstock, Jean S. Cavallo, Souad Naimi, Anne-Marie Galzin, Etienne Guillot, Marie-Pierre Pruniaux, Michael J. Tocci, H. Greg Polites
Obesity 2011
Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies
Sara Jane Ward, Robert B. Raffa
Obesity 2011
Rimonabant: From RIO to Ban
Amir H. Sam, Victoria Salem, Mohammad A. Ghatei
Journal of Obesity 2011
Large Size Cells in the Visceral Adipose Depot Predict Insulin Resistance in the Canine Model
Morvarid Kabir, Darko Stefanovski, Isabel R. Hsu, Malini Iyer, Orison O. Woolcott, Dan Zheng, Karyn J. Catalano, Jenny D. Chiu, Stella P. Kim, Lisa N. Harrison, Viorica Ionut, Maya Lottati, Richard N. Bergman, Joyce M. Richey
Obesity 2011
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
Louis J. Aronne, Nick Finer, Priscilla A. Hollander, Richard D. England, Solomon S. Klioze, Robert D. Chew, Robert J. Fountaine, Coralie M. Powell, John D. Obourn
Obesity 2011
Pharmacological treatment of obesity in children and adolescents: present and future.
Lorenzo Iughetti, Mariachiara China, Rossella Berri, Barbara Predieri
Journal of Obesity 2011
Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors
R S Vijayakumar, Y Lin, K-S Shia, Y-N Yeh, W-P Hsieh, W-C Hsiao, C-P Chang, Y-S Chao, M-S Hung
Int J Obes Relat Metab Disord 2011
The CB1 Receptor Antagonist SR141716A Reverses Adult Male Mice Overweight and Metabolic Alterations Induced by Early Stress
Carina A. Valenzuela, Valeska A. Castillo, Carolina A. Aguirre, Ana M. Ronco, Miguel N. Llanos
Obesity 2010
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G Muccioli, Damien Naslain, Fredrik Bäckhed, Christopher S Reigstad, Didier M Lambert, Nathalie M Delzenne, Patrice D Cani
Mol Syst Biol 2010
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
L J Aronne, S Tonstad, M Moreno, I Gantz, N Erondu, S Suryawanshi, C Molony, S Sieberts, J Nayee, A G Meehan, D Shapiro, S B Heymsfield, K D Kaufman, J M Amatruda
Int J Obes Relat Metab Disord 2010